Morgan Stanley has upgraded Lemonade's rating and price target to $85, highlighting a significant growth potential, particularly in autonomous insurance. The discount for Tesla drivers makes LMND appealing, positioning the company for further expansion in the autonomous market, which could drive revenues substantially.
C-level executives sold shares, indicating possible lack of confidence. LMND is under short-term pressure despite long-term uptrend. Current stock price is below key moving averages, signaling weakness. Consensus among analysts shows a 'sell' rating with low price targets. LMND has significantly outperformed the NYSE year-to-date.